Trademark: 97068218
Word
KLIRFIBA
Status Date
Monday, June 3, 2024
Filing Date
Monday, October 11, 2021
Published for Opposition
Tuesday, April 12, 2022
5 Pharmaceutical preparations for the treatment of inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, protein aggregation-related diseases and disorders, neurodegenerative diseases and disorders
Oct 14, 2021
New Application Entered
Nov 2, 2021
New Application Office Supplied Data Entered
Feb 25, 2022
Assigned To Examiner
Mar 7, 2022
Approved For Pub - Principal Register
Mar 23, 2022
Notification Of Notice Of Publication E-Mailed
Apr 12, 2022
Published For Opposition
Apr 12, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 7, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 22, 2022
Sou Teas Extension Received
Nov 22, 2022
Sou Extension 1 Filed
Nov 22, 2022
Sou Extension 1 Granted
Nov 24, 2022
Notice Of Approval Of Extension Request E-Mailed
May 6, 2023
Sou Teas Extension Received
May 6, 2023
Sou Extension 2 Filed
May 6, 2023
Sou Extension 2 Granted
May 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 10, 2023
Sou Teas Extension Received
Nov 10, 2023
Sou Extension 3 Filed
Nov 10, 2023
Sou Extension 3 Granted
Nov 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 11, 2024
Teas Change Of Correspondence Received
Apr 11, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 11, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
May 24, 2024
Teas Change Of Correspondence Received
May 24, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 24, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 3, 2024
Sou Teas Extension Received
Jun 3, 2024
Sou Extension 4 Granted
Jun 3, 2024
Sou Extension 4 Filed
Jun 13, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
